The quality of products in general is of great importance in the current time, and its impact on various aspects of life, such as economy, health and welfare of society as a whole is crucial and visible. It is vital to have a deep understanding of th
e product realization process, including understanding the dynamics under which the product quality changes
under the manufacturing conditions and the customer’s
(sensitivity) ability to recognize changes in product quality.
This article aims to develop and modify the Taguchi model
to suit the case of pharmaceutical products. The model of
pharmaceutical quality loss suggested in this paper can be
considered as a combination of the traditional concept of
quality model and the Taguchi model, modified to suit the
case of the pharmaceutical quality. The suggested quality
model can be used to assess quantitatively the quality
loss value that is associated with each deviation from the established tolerance zone; and accordingly to enhance the understanding of the pharmaceutical manufacturing process to avoid and prevent the occurrence of such loses of the pharmaceutical quality in the future.
